TECNO_Trial Profile Banner
The TECNO Profile
The TECNO

@TECNO_Trial

Followers
185
Following
181
Media
9
Statuses
411

Safety and Efficacy of Intra-Arterial Tenecteplase for Non-Complete Reperfusion of Intracranial Occlusions (https://t.co/nWJOSnptNm ID: NCT05499832)

Berne, Switzerland
Joined April 2022
Don't wanna be here? Send us removal request.
@ESOstroke
European Stroke Org
14 days
🧠You can still register for the #WSC2025 Highlights Webinar — hosted by ESO, @WorldStrokeOrg and @American_Stroke. Get key updates in stroke research & care. 🔗 https://t.co/Elo9Azcya4 #Stroke #StrokeScience #StrokeEducation #Neurology @SposatoL @eva_mistry @jeyaraj_pandian
0
13
29
@sheilambrasil
sheila martins
17 days
📣 Calling all stroke specialists in Latin America! Join us in São Paulo, Dec 2–5 2025, for the first Latin America Stroke Summer School from University of Bern in partnership with Rede Brasil AVC and ESO, endorsed by WSO. 🎥 Check out Urs Fischer’s invitation and get ready for
4
18
32
@DOIT_trial
DO-IT Trial
1 month
🔊 Exciting DO-IT Trial Update!🔊 📈 🌍 The trial continues to expand, with 23 sites actively recruiting across Europe and 30 patients enrolled so far! 👏 A big thank you to everyone contributing! 💉🧑‍⚕️Recruit. Care. Cure. DO-IT!
0
16
21
@Diana_A_Sousa
Diana Aguiar de Sousa
1 month
Honoured that our team in Lisbon could enrol the 156th patient. Grateful to patients, families, and all collaborators. Now looking forward to the results! TECNO is a clinically relevant trial with the potential to change practice. @TECNO_Trial @inselgruppe @StrokeBern
@TECNO_Trial
The TECNO
1 month
We have successfully reached target enrollment 🎉 A huge THANK YOU to all patients, their families, participating centers & investigators for their work 💿 We thank the Lisbon team 🇵🇹 for including the 156th patient @Diana_A_Sousa 🙏 @inselgruppe @StrokeBern @MedFacultyUniBE
0
2
6
@TECNO_Trial
The TECNO
1 month
We have successfully reached target enrollment 🎉 A huge THANK YOU to all patients, their families, participating centers & investigators for their work 💿 We thank the Lisbon team 🇵🇹 for including the 156th patient @Diana_A_Sousa 🙏 @inselgruppe @StrokeBern @MedFacultyUniBE
0
9
14
@JAMANeuro
JAMA Neurology
2 months
In anterior circulation stroke patients post-thrombectomy, low and medium doses of intra-arterial tenecteplase demonstrated adequate safety to warrant larger trials to investigate their therapeutic potential. https://t.co/yWAe7yPCSN
0
27
62
@TECNO_Trial
The TECNO
2 months
🚨 TECNO trial update 🚨 131 patients enrolled! Only 25 more to hit our target of 156 - the final countdown is on 🏁 We sincerely thank all the centers and investigators on their efforts! 💪 #TECNO 💿
1
12
21
@TECNO_Trial
The TECNO
2 months
0
0
0
@TECNO_Trial
The TECNO
2 months
🚨 TECNO trial update 🚨 131 patients enrolled! Only 25 more to hit our target of 156 - the final countdown is on 🏁 We sincerely thank all the centers and investigators on their efforts! 💪 #TECNO 💿
1
12
21
@JAMANeuro
JAMA Neurology
2 months
In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability compared to medical management alone. https://t.co/rasJRzAqRq
1
42
142
@StrokeSchool
StrokeWinterSchool
2 months
0
12
15
@DavidSeiffge
David Seiffge
3 months
@GreenJournal
Neurology Journal
3 months
Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #stroke in patients with #AtrialFibrillation. Listen now: https://t.co/5OrxanHR0D #NeuroTwitter @DrDanAckerman
0
8
14
@FishingNeurons
Urs Martin Fischer
3 months
Many thanks for the opportunity to discuss the CATALYST meta-analysis and our ongoing trials (ELAPSE and DO IT). @BoNorrving @SignildAsberg @DavidSeiffge @TotoMynell @unibern
@GreenJournal
Neurology Journal
3 months
Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #stroke in patients with #AtrialFibrillation. Listen now: https://t.co/5OrxanHR0D #NeuroTwitter @DrDanAckerman
0
18
42
@FishingNeurons
Urs Martin Fischer
3 months
I have been invited to talk about our CATALYST meta-analysis in the ‚Neurology Podcast‘. Press the button below and find out more on CATALYST, but also on our ELAPSE and DO IT trials. ⁦@BoNorrving⁩ ⁦@SignildAsberg⁩ ⁦@SeiffgeDavid
1
17
46
@JAMANeuro
JAMA Neurology
3 months
Most viewed this week from @JAMANeuro: Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. https://t.co/VSOzhlOsmk
0
12
29
@IntJStroke
International Journal of Stroke
3 months
🧠Decompressive craniectomy ⬇️reduces mortality and ⬆️improves neurological function in selected spontaneous ICH patients vs best medical treatment alone Read more below!👇 https://t.co/4V7OQk0ri5
0
30
84
@JAMANeuro
JAMA Neurology
3 months
Most viewed this week from @JAMANeuro: Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. https://t.co/3OVYNSJDzb
1
17
31
@StrokeSchool
StrokeWinterSchool
3 months
🚨 Registration for Stroke Winter School 2026 is NOW OPEN! 🚨 Join stroke physicians and neuroradiologists in an exclusive course designed to boost interdisciplinary stroke care. Don’t miss out—secure your spot today! @ESOstroke @esmintsociety @ESNRad
0
7
8
@ESOstroke
European Stroke Org
3 months
Dr Costru-Tașnic reflects on her inspiring journey as part of the 2024–2026 European Stroke Master Programme in Bern, supported by an ESO scholarship. She brings fresh ideas to improve stroke care in Moldova. 🔗 https://t.co/bSGqfhIUtH 📣 Apply: https://t.co/QcjSIuPad3 #Stroke
0
8
10
@FishingNeurons
Urs Martin Fischer
3 months
Does intravenous thrombolysis prior endovascular treatment (EVT) increases the risk of intracranial haemorhage compared to EVT alone? Check our latest article in JAMA Neurology! @StrokeBern @CheesemakerMD @fabianoca @kiliantreurniet @manonkappelhof @TotoMynell
@JAMANeuro
JAMA Neurology
3 months
Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. https://t.co/O0Biy9VKVU
0
20
44